戻る
Eagle Pharmaceuticals Inc (EGRX)価格
EGRX 株価推移チャート
EGRX 収入
Eagle Pharmaceuticals Inc
$0.85
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.5
-41.17%
$-0.35
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.85
始値
$1.5
当日レンジ
$0.5 - $1.5
52週レンジ
$0.1 - $3.87
取引高
100
平均取引高
4.1K
1株当たり利益(TTM)
0.92
配当利回り
--
時価総額
$6.4M
EGRXとは何ですか？
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company is headquartered in Woodcliff Lake, New Jersey and currently employs 134 full-time employees. The company went IPO on 2014-02-12. The firm is focused on developing medicines that result in improvements in patients' lives. The firm's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The firm also has a research and development facility in Cambridge, Massachusetts. The firm is also focused on developing medicines with the potential to become part of the personalized medicine paradigm in cancer care. The firm has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana.